Valuation Alkem Laboratories Limited

Stocks

Market Closed - NSE India S.E. Other stock markets 07:05:07 2026-06-19 EDT			5-day change	1st Jan Change
5,373.50 ^INR	+0.03%		+1.43%	-2.42%

06-02	Alkem Laboratories Shows Strong Moves But Weak Follow-Through
05-29	Bob Capital Markets Downgrades Alkem Laboratories to Sell From Hold; Price Target is INR4,638	MT

Data adjusted to current consolidation scope

Fiscal Period: March	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	331,171	432,909	406,055	590,890	583,680	642,483	-	-
Change	-	30.72%	-6.2%	45.52%	-1.22%	10.07%	-	-
Enterprise Value (EV) ¹	328,603	433,805	393,853	587,236	578,678	632,481	612,008	598,428
Change	-	32.02%	-9.21%	49.1%	-1.46%	9.3%	-0.38%	-2.22%
P/E	20.9x	26.3x	41.3x	32.9x	27x	27.5x	27.4x	23.8x
PBR	4.49x	5.01x	4.49x	5.73x	4.87x	4.58x	4.15x	3.67x
PEG	-	6.89x	-1x	0.4x	1.3x	4.37x	-3.76x	1.6x
Capitalization / Revenue	3.74x	4.07x	3.5x	4.66x	4.5x	4.31x	3.88x	3.52x
EV / Revenue	3.71x	4.08x	3.4x	4.64x	4.46x	4.3x	3.7x	3.28x
EV / EBITDA	16.9x	21.1x	24.5x	26.2x	23x	21x	17.9x	15.4x
EV / EBIT	19.7x	24.8x	30.3x	30.2x	26.9x	24.1x	20.6x	17.6x
EV / FCF	30.4x	55.4x	27.1x	33.3x	45.3x	42.8x	33.8x	28.8x
FCF Yield	3.29%	1.81%	3.69%	3%	2.21%	2.33%	2.96%	3.48%
Dividend per Share ²	28	34	25	40	45	53	51.49	56.66
Rate of return	1.01%	0.94%	0.74%	0.81%	0.92%	1%	0.96%	1.05%
EPS ²	132.6	137.6	82.31	150.2	181.1	192.5	196	225.4
Distribution rate	21.1%	24.7%	30.4%	26.6%	24.8%	27.5%	26.3%	25.1%
Net sales ¹	88,650	106,342	115,993	126,676	129,645	147,123	165,551	182,526
EBITDA ¹	19,424	20,529	16,094	22,455	25,122	30,052	34,136	38,956
EBIT ¹	16,678	17,490	12,990	19,462	21,550	26,232	29,663	34,038
Net income ¹	15,850	16,456	9,842	17,958	21,655	23,018	23,923	27,679
Net Debt ¹	-2,568	896.1	-12,202	-3,654	-5,003	-1,094	-30,475	-44,054
Reference price ²	2,769.80	3,620.70	3,396.10	4,942.00	4,881.70	5,373.50	5,373.50	5,373.50
Nbr of stocks (in thousands)	119,565	119,565	119,565	119,565	119,565	119,565	-	-
Announcement Date	5/25/21	5/13/22	5/19/23	5/29/24	5/29/25	5/28/26	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ALKEM LABORATORIES LIMITED	25.42x	4.2x	20.31x	1%	6.81B
ELI LILLY AND COMPANY	32.01x	11.69x	23.99x	0.62%	980B
JOHNSON & JOHNSON	24.41x	5.63x	15.32x	2.34%	550B
ABBVIE INC.	26.86x	6.49x	13.28x	3.17%	382B
ROCHE HOLDING AG	17.04x	4.24x	10.43x	3.13%	316B
ASTRAZENECA PLC	21.94x	4.59x	13.02x	1.91%	272B
NOVARTIS AG	20.28x	5.27x	12.78x	3.05%	268B
NOVO NORDISK A/S	13x	4.83x	9.94x	3.87%	199B
AMGEN INC.	21.95x	5.91x	10.33x	2.99%	182B
GILEAD SCIENCES, INC.	-44.34x	5.36x	29.54x	2.62%	154B
Average	15.86x	5.82x	15.89x	2.47%	330.91B
Weighted average by Cap.	21.69x	7.23x	16.86x	2.16%